MedPath

Post stationary telemedical care of patients with severe psychiatric disorders

Not Applicable
Conditions
F20F25.SCHIZOAFFEKTIVESTOERUNGENF31.BIPOLARESTOERUNGE
Registration Number
DRKS00008548
Lead Sponsor
niversitätsmedizin Greifswald
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
121
Inclusion Criteria

Medical diagnosis of schizophrenia, schizoaffective disorder or bipolar disorder. Signed consent to study participation.

Exclusion Criteria

Planned hospitalization in the next 6 months. No telephone access.

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
The primary endpoint is the evaluation medication adherence. The assesssment instrument is the MARS-D (German version of the Medication Adherence Report Scale). Times of measurement are baseline, 3- and 6-months-follow ups. The hypothesis is that after 6 months, the medication adherence in the intervention group is better than the control group.
Secondary Outcome Measures
NameTimeMethod
Secondary endpoints compare the frequency of anew and unplanned psychiatric (partly) inpatient stays, the periods until the unplanned (partly) inpatient treatment as well as quality of life, coping with everyday life and the development of symptoms within each of the 6 months.<br>Data of unplannend readmissions are recorded with computer assistance. The quality of life is measured by the questionnaire WHOQOL-BREF (World Health Organsiation Quality Of Life), coping with everyday life with GAF (Global Assessment of Functioning) and symptoms with BPRS (Brief Psychiatric Rating Scale). Measurement times are baseline, 3- and 6-month follow-ups.
© Copyright 2025. All Rights Reserved by MedPath